Striking differences seen in COVID-19 responses in cancer patients

Study shows that high levels of COVID-19 antibodies are sustained long-term in patients with solid tumours. Research findings suggest many patients despite being on immunosuppressive therapies may respond satisfactorily to COVID-19 vaccines.

Please sign in or register for FREE

No comments yet.